Data as of Oct 22
| -0.52 / -1.08%|
The 20 analysts offering 12-month price forecasts for ResMed Inc have a median target of 51.90, with a high estimate of 68.21 and a low estimate of 39.00. The median estimate represents a +9.27% increase from the last price of 47.50.
The current consensus among 24 polled investment analysts is to Hold stock in ResMed Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.